Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R, Kishida T, Sakaguchi M, Yokose T, Yasui M, Hashizume A, Tatenuma T, Mizuno N, Muraoka K, Umemoto S, Kawai M, Yoshihara M, Nakamura Y, Miyagi Y, Sasada T. Jikuya R, et al. Among authors: muraoka k. Cancer Immunol Immunother. 2020 Oct;69(10):2041-2051. doi: 10.1007/s00262-020-02608-6. Epub 2020 May 18. Cancer Immunol Immunother. 2020. PMID: 32424467 Free PMC article.
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.
Noguchi G, Nakaigawa N, Umemoto S, Kobayashi K, Shibata Y, Tsutsumi S, Yasui M, Ohtake S, Suzuki T, Osaka K, Muraoka K, Hasumi H, Kondo K, Igarashi Y, Sasada T, Kishida T, Yao M. Noguchi G, et al. Among authors: muraoka k. Cancer Chemother Pharmacol. 2020 Jul;86(1):75-85. doi: 10.1007/s00280-020-04088-y. Epub 2020 Jun 14. Cancer Chemother Pharmacol. 2020. PMID: 32537714
[A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
Jikuya R, Washimi K, Yasui M, Hashizume A, Tatenuma T, Mizuno N, Muraoka K, Umemoto S, Kawai M, Kishida T. Jikuya R, et al. Among authors: muraoka k. Hinyokika Kiyo. 2017 Jun;63(6):245-249. doi: 10.14989/ActaUrolJap_63_6_245. Hinyokika Kiyo. 2017. PMID: 28694418 Free article. Japanese.
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Nakaigawa N, Kondo K, Kaneta T, Tateishi U, Minamimoto R, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Hayashi N, Osaka K, Muraoka K, Izumi K, Kawahara T, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Inoue T, Yao M. Nakaigawa N, et al. Among authors: muraoka k. Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20. Cancer Chemother Pharmacol. 2018. PMID: 29464355
[A Case of Lymphoepithelioma-Like Carcinoma of the Ureter].
Fujita Y, Suzuki A, Asaoka M, Jikuya R, Mitome T, Ohtake S, Tatenuma T, Yamanaka H, Ito Y, Muraoka K, Makiyama K, Kondo K, Nakaigawa N, Enaka M, Yao M. Fujita Y, et al. Among authors: muraoka k. Hinyokika Kiyo. 2021 May;67(5):205-209. doi: 10.14989/ActaUrolJap_67_5_205. Hinyokika Kiyo. 2021. PMID: 34126664 Free article. Japanese.
302 results